Source: Journal of cardiovascular magnetic resonance. Unidade: FM
Subjects: MIOCARDIOPATIA HIPERTRÓFICA, MORTE SÚBITA CARDÍACA, FATORES DE RISCO, RESSONÂNCIA MAGNÉTICA, GADOLÍNIO, DESFIBRILADORES, PRÓTESES E IMPLANTES
ABNT
FREITAS, Pedro et al. The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death. Journal of cardiovascular magnetic resonance, v. 21, n. 1, 2019Tradução . . Disponível em: https://doi.org/10.1186/s12968-019-0561-4. Acesso em: 28 ago. 2024.APA
Freitas, P., Ferreira, A. M., Arteaga-Fernandez, E., Antunes, M. de O., Mesquita, J., Abecasis, J., et al. (2019). The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death. Journal of cardiovascular magnetic resonance, 21( 1). doi:10.1186/s12968-019-0561-4NLM
Freitas P, Ferreira AM, Arteaga-Fernandez E, Antunes M de O, Mesquita J, Abecasis J, Marques H, Saraiva C, Matos DN, Mady C. The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death [Internet]. Journal of cardiovascular magnetic resonance. 2019 ; 21( 1):[citado 2024 ago. 28 ] Available from: https://doi.org/10.1186/s12968-019-0561-4Vancouver
Freitas P, Ferreira AM, Arteaga-Fernandez E, Antunes M de O, Mesquita J, Abecasis J, Marques H, Saraiva C, Matos DN, Mady C. The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death [Internet]. Journal of cardiovascular magnetic resonance. 2019 ; 21( 1):[citado 2024 ago. 28 ] Available from: https://doi.org/10.1186/s12968-019-0561-4